Beijing to Let Some Low-Risk Patients Home Quarantine as Covid Soars + Some Notes

Bloomberg: Beijing to Let Some Low-Risk Patients Home Quarantine as Covid Soars

Global Times: Flexible measures implemented across China to ensure people’s livelihoods amid cold front

China actually started relaxing it’s Zero-COVID polices on November 11th. The mNRA vaccine hasn’t been approved, yet. The West is pushing for China to use mNRA vaccines.

Related:

05-09-2022: Dropping zero-COVID policy in China without safeguards risks 1.5m lives – study

China’s refusal to use Western COVID-19 vaccines is making its protest problems even worse

Read More »

Compound in red wine, chocolate prevents smallpox virus cousins from replicating

Disclaimer: The information posted here is not a substitute for professional medical advice, diagnosis or treatment. Please seek the advice of a medical professional before taking any supplements!

Compound in red wine, chocolate prevents smallpox virus cousins from replicating

“Resveratrol is a small, natural compound in many plants like grapes, cocoa beans, peanuts and blueberries,” said Shuai Cao, postdoctoral researcher studying the effects of resveratrol on viruses. “Our recent study found that high concentrations of resveratrol — higher than anything you may find in food naturally — prevent poxviruses from replicating in human cells.”

The Kansas State University researchers recorded resveratrol’s success with vaccinia and collaborated with researchers at the CDC to perform similar experiments with monkeypox, a contagious and deadly virus to humans that has caused periodic disease outbreaks in Africa. Resveratrol had the same effect with monkeypox, which means that it has a good chance of inhibiting all poxviruses, Cao said.

Related:

I remember the following study of Resveratrol’s effects on SARS-CoV-2:

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

To determine which phase of the viral life cycle resveratrol exerts its effects, they conducted two sets of experiments. In one set, they treated the cells with resveratrol before infection; and in another set, resveratrol was administered to SARS-CoV-2 infected cells. Interestingly, the findings revealed that resveratrol, when applied before infection, was capable of inhibiting the viral replication only by 20%; whereas, post-treatment with resveratrol caused a 98% reduction in viral replication. These findings suggest that resveratrol is more efficacious in the presence of the virus.

To further investigate the mode of action of resveratrol, they incubated the cells with both SARS-CoV-2 and resveratrol at the same time and observed that resveratrol could inhibit viral replication by 64%. These findings suggest that resveratrol may be capable of preventing viral entry into the cells.

Resveratrol Side Effects and Health Hazards <~~can affect how blood pressure, anti-coagulant, and anti-platelet medications work. It can also increase the risk of bleeding during and after surgery.

Resveratrol – Uses, Side Effects, And More <~~can interact with some medications and other supplements.

The FDA loves horse medicine if it’s really expensive, still under patent, and toxic (Fauci, Baric, Denison, DTRA & Gilead Sciences)

The FDA loves horse medicine if it’s really expensive, still under patent, and toxic

Related:

Study shows effectiveness of pill form of remdesivir to treat COVID-19 in mice (Ralph Baric & Gilead Sciences)**

Molnupiravir & Ivermectin’s Equine Connections

An emerging antiviral takes aim at COVID-19

[Molnupiravir] EIDD-2801’s story starts years before the coronavirus crisis. In 2014, Painter and his colleagues at Emory University began a project funded by the Defense Threat Reduction Agency to find an antiviral compound that could fight Venezuelan equine encephalitis virus (VEEV). During the Cold War, both the US and the Soviet Union studied VEEV as a potential biological weapon. Typically transmitted through mosquito bites, VEEV causes high fevers, headaches, and sometimes encephalitis, swelling of the brain that can be deadly.

In late 2019, Painter got a contract from the National Institute of Allergy and Infectious Diseases* to move EIDD-2801 into Phase I clinical trials for influenza. The plan was to file an investigational new drug application and find a partner to help with the clinical work.

Just as the team was contemplating its next move, word of a virus spreading in Wuhan, China, was starting to make news. One of Painter’s collaborators, UNC coronavirus expert Ralph Baric**, immediately alerted him that the new pathogen was probably a coronavirus—one that EIDD-2801 could potentially combat.

Denison*** says the research team knew a coronavirus outbreak was inevitable. “Every single one of our grants, every single one of our papers predicted that this event was going to happen that’s occurring right now,” he says. “The whole goal of our drug development was to plan for this.”

*Anthony Fauci, director of NIAID.

**Ralph Baric, patents.

***Mark Denison (Denison Lab/Vanderbilt University Medical Center & Gilead Sciences)

US vaccine for coronavirus could take at least a year

McCaffery said the Defense Department’s research on a potential antiviral therapy, a medicine that could be effective in helping those infected with coronavirus get well, may be closer to release.

“We may be closer there in terms of having something that can be usable, it’s actually in clinical trials right now,” he said.

— Read on web.archive.org/web/20200306171227/https://www.mcclatchydc.com/news/nation-world/national/national-security/article240922051.html